Given that SIRT2 is thought to promote vascular endothelial growth factor A (VEGF-A) signalling and endothelial-like tube formation in tumour angiogenesis (Hu et al., 2018), specific inhibitors have also been developed. The gene discussed is VEGFA; the disease is neoplasm.